July 31, 2022

Stephanie Wisner

In this episode of the Life Science Success podcast I interviewed Stephanie Wisner.  We discussed Co-Founding Centivax and her new book Building Backwards to Biotech: the Power of Entrepreneurship to Drive Cutting-Edge Science to Market.


In this episode of the Life Science Success podcast I interviewed Stephanie Wisner.  We discussed Co-Founding Centivax and her new book Building Backwards to Biotech: the Power of Entrepreneurship to Drive Cutting-Edge Science to Market.

Please check out our Life Science Success Resources.  You will find tools that will support growing companies and books for authors I have interviewed.  

Transcript

1:00 Introduction

4:00 Starting to work with Jacob Glanville

7:00 Premise of the Book Building Backwards to Biotech

13:00 Mitigating Scientific Risk

18:00 Bringing New Drugs to Market

22:00  Interviews and references in the book

24:00 Three Questions:

What inspires you?

What concerns you?

What excites you?

Stephanie Wisner Profile Photo

Stephanie Wisner

Stephanie A. Wisner

Stephanie A. Wisner co-founded the biotech start-up, Centivax, where she is now Chief Business Officer. She has also advised multiple biotech start-ups on business and commercialization strategy through her consulting business, BioVenture Advising LLC. In 2022, she was named to the Forbes 30 Under 30 list for Healthcare. Her first book, Building Backwards to Biotech, was published in 2022 and was a #1 best seller on Amazon in Biotechnology. She completed her MBA at the University of Chicago Booth School of Business, with concentrations in finance, accounting, and entrepreneurship. She received her Bachelor’s Degree in chemistry and chemical biology from Cornell University and was awarded the Einhorn Discovery Research Grant for her independent research on cancer. While she no longer gets as much time in the lab, she enjoys the travel and continuous learning this career involves.